ATE170076T1 - Angiotensin ii-antagonisten zur behandlung von viralen erkrankungen - Google Patents
Angiotensin ii-antagonisten zur behandlung von viralen erkrankungenInfo
- Publication number
- ATE170076T1 ATE170076T1 AT94102791T AT94102791T ATE170076T1 AT E170076 T1 ATE170076 T1 AT E170076T1 AT 94102791 T AT94102791 T AT 94102791T AT 94102791 T AT94102791 T AT 94102791T AT E170076 T1 ATE170076 T1 AT E170076T1
- Authority
- AT
- Austria
- Prior art keywords
- angiotensin
- antagonists
- treatment
- viral diseases
- diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 230000003612 virological effect Effects 0.000 title abstract 3
- 229940123413 Angiotensin II antagonist Drugs 0.000 title abstract 2
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000005779 cell damage Effects 0.000 abstract 1
- 208000037887 cell injury Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3823493 | 1993-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE170076T1 true ATE170076T1 (de) | 1998-09-15 |
Family
ID=12519615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94102791T ATE170076T1 (de) | 1993-02-26 | 1994-02-24 | Angiotensin ii-antagonisten zur behandlung von viralen erkrankungen |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5605919A (de) |
| EP (1) | EP0612524B1 (de) |
| JP (1) | JP2787539B2 (de) |
| AT (1) | ATE170076T1 (de) |
| CA (1) | CA2116388C (de) |
| DE (1) | DE69412662T2 (de) |
| DK (1) | DK0612524T3 (de) |
| ES (1) | ES2121103T3 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2787539B2 (ja) * | 1993-02-26 | 1998-08-20 | 松森 昭 | ウイルス性疾患の予防または治療剤 |
| US5945425A (en) | 1994-04-29 | 1999-08-31 | G.D. Searle & Co. | Method of using (H+ /K+)ATPase inhibitors as antiviral agents |
| US6037456A (en) * | 1998-03-10 | 2000-03-14 | Biosource Technologies, Inc. | Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| US6770666B2 (en) * | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
| PL356422A1 (en) * | 2000-02-18 | 2004-06-28 | Takeda Chemical Industries, Ltd. | Tnf-alpha inhibitors |
| US20060135422A1 (en) * | 2003-04-17 | 2006-06-22 | Moskowitz David W | Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE |
| US7157584B2 (en) * | 2004-02-25 | 2007-01-02 | Takeda Pharmaceutical Company Limited | Benzimidazole derivative and use thereof |
| WO2006099058A2 (en) * | 2005-03-09 | 2006-09-21 | Nitromed, Inc. | Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| AU2006290442B2 (en) | 2005-09-16 | 2010-07-29 | Arrow Therapeutics Limited | Biphenyl derivatives and their use in treating hepatitis C |
| AR065850A1 (es) * | 2007-03-28 | 2009-07-08 | Takeda Pharmaceutical | Composicion farmaceutica solida que comprende un derivado de benzimidazol-7-carboxilato y un agente de control de ph |
| WO2009148961A2 (en) * | 2008-05-29 | 2009-12-10 | Wisconsin Alumni Research Foundation | Drugs to prevent hpv infection |
| WO2010127246A2 (en) * | 2009-04-30 | 2010-11-04 | Burnham Institute For Medical Research | Hnf4 modulators and methods of use |
| EP3638230A4 (de) * | 2017-06-13 | 2021-04-21 | Commonwealth Scientific and Industrial Research Organisation | Antivirale arzneimittel |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1076582A (en) * | 1975-10-28 | 1980-04-29 | Charles J. Paget | Antiviral thiazolinyl or thiazinyl ketobenzimidazoles |
| US4420479A (en) * | 1982-04-08 | 1983-12-13 | Eli Lilly And Company | Olefinic benzimidazoles, formulations, and antiviral methods |
| CA1279648C (en) * | 1986-07-11 | 1991-01-29 | Haruo Kuriyama | 2-(4-pyridylaminometyl)-benzimidazole derivatives having antiviral activity |
| NZ225045A (en) * | 1987-07-01 | 1990-06-26 | Janssen Pharmaceutica Nv | Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent |
| IL95975A (en) * | 1989-10-24 | 1997-06-10 | Takeda Chemical Industries Ltd | N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them |
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| IE68045B1 (en) * | 1990-05-11 | 1996-05-15 | Abbott Lab | Renin inhibitors |
| EP0665215A1 (de) * | 1990-06-01 | 1995-08-02 | The Du Pont Merck Pharmaceutical Company | 1,4-Diamino-2,3-dihydroxybutanen |
| US5248672A (en) * | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
| IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them |
| JP2787539B2 (ja) * | 1993-02-26 | 1998-08-20 | 松森 昭 | ウイルス性疾患の予防または治療剤 |
-
1994
- 1994-02-23 JP JP6025120A patent/JP2787539B2/ja not_active Expired - Lifetime
- 1994-02-23 US US08/200,686 patent/US5605919A/en not_active Expired - Lifetime
- 1994-02-24 ES ES94102791T patent/ES2121103T3/es not_active Expired - Lifetime
- 1994-02-24 AT AT94102791T patent/ATE170076T1/de active
- 1994-02-24 EP EP94102791A patent/EP0612524B1/de not_active Expired - Lifetime
- 1994-02-24 DK DK94102791T patent/DK0612524T3/da active
- 1994-02-24 DE DE69412662T patent/DE69412662T2/de not_active Expired - Lifetime
- 1994-02-24 CA CA002116388A patent/CA2116388C/en not_active Expired - Lifetime
-
1996
- 1996-10-24 US US08/736,593 patent/US5750551A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5750551A (en) | 1998-05-12 |
| DK0612524T3 (da) | 1999-05-25 |
| ES2121103T3 (es) | 1998-11-16 |
| CA2116388A1 (en) | 1994-08-27 |
| JPH06305965A (ja) | 1994-11-01 |
| EP0612524B1 (de) | 1998-08-26 |
| EP0612524A1 (de) | 1994-08-31 |
| DE69412662T2 (de) | 1999-01-07 |
| US5605919A (en) | 1997-02-25 |
| CA2116388C (en) | 2007-03-13 |
| DE69412662D1 (de) | 1998-10-01 |
| JP2787539B2 (ja) | 1998-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118651T1 (el) | Αζακυκλικες ενωσεις για χρηση στην θεραπευτικη αντιμετωπιση ασθενειων που σχετιζονται με τη σεροτονινη | |
| EA199700117A1 (ru) | Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE61523T1 (de) | Mittel zur verabreichung von hyaluronsaeure an saeuger. | |
| DK0913156T3 (da) | Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis | |
| DE69412662D1 (de) | Angiotensin II-Antagonisten zur Behandlung von viralen Erkrankungen | |
| ATE535255T1 (de) | Anti-tnf antikörper und methotrexat zur gleichzeitigen behandlung von autoimmunkrankheiten | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| NO902632L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolyl-alkensyrer. | |
| BG103521A (en) | Substituted pyrimidinon and pyridon compounds and methods for their application | |
| DE69507029D1 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
| ES2177780T3 (es) | Medicamentos para el tratamiento de enfermedades autoinmunes usando interferon tau. | |
| DE69717148D1 (de) | 3-pyridylenantiomere und ihre verwendung als analgetika | |
| DE68912459D1 (de) | Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten. | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| DE69327328D1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| ES2153842T3 (es) | Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central. | |
| BG103512A (en) | Substituted pyramidine compounds and their application | |
| DE69926794D1 (de) | Ponazuril zur behandlung von durch coccidia neurologischen und "abortigenic" verursachten erkrankungen | |
| EE9800315A (et) | Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil | |
| ATE222768T1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen | |
| DK0768083T3 (da) | Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt | |
| NO971453D0 (no) | Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |